reports
BioDelivery Sciences International Announces ELYXYB™ is Now Available ...
BioDelivery Sciences International Announces ELYXYB™ is Now Available in the U.S. for the Acute Treatment of Migraine The First and Only FDA-Approved, Ready-to-Use Oral Solution for the Acute Treatment of Migraine with or without Aura in Adults Expands BDSI Portfolio and Establishes Growth Platform in Neurology RALEIGH, N.C., Feb. 24, 2022 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced the U.S. commercial launch and availa...
Collegium to Acquire BioDelivery Sciences in an All-Cash Deal
Collegium to Acquire BioDelivery Sciences in an All-Cash Deal Transaction is valued at $5.60 per share representing a total equity value of $604 million Represents a 54% premium to BDSI stock’s closing price of $3.64 on February 11, 2022 and a 65% premium to the 30 trading days volume weighted average price of $3.40 Transaction expected to close late in the first quarter of 2022 RALEIGH, N.C., Feb. 14, 2022 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic...
BioDelivery Sciences Expects 2021 Revenue at the High End of Full Year...
BioDelivery Sciences Expects 2021 Revenue at the High End of Full Year Guidance Total 2021 Net Revenue expected in the range of $165 -$167 million, as compared to previous guidance of $162-$167 million BELBUCA 2021 Net Sales expected to be in the range of $147 -$148 million, as compared to previous guidance of $144-$148 million 2021 EBITDA expected to be in the $40 - $45 million range as compared with previous guidance of
BIODELIVERY SCIENCES sees an upgrade to Slightly Positive due to a bet...
The general evaluation of BIODELIVERY SCIENCES (US), a company active in the Biotechnology industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date December 21, 2021, the closing pric...
BioDelivery Sciences Prevails in BELBUCA® ANDA Litigation Maintaining ...
BioDelivery Sciences Prevails in BELBUCA® ANDA Litigation Maintaining Patent Exclusivity Against Alvogen Until 2032 RALEIGH, N.C., Dec. 20, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that the U.S. District Court of Delaware has issued an opinion in favor of BDSI in the company’s patent litigation against Alvogen Group, Inc. and its affiliates, who filed an Abbreviated New Drug Application (ANDA) for BDSI’s BELBUCA® prod...
- Jonathan Moreland
UEPS NET 1 U.E.P.S. TECHNOLOGIES INC.
SYNL SYNALLOY CORP.
RVNC REVANCE THERAPEUTICS INC.
RDUS RADIUS HEALTH INC.
PRLB PROTO LABS INC.
PRGO PERRIGO CO. PLC
HQY HEALTHEQUITY INC
FFIN FIRST FINANCIAL BANKSHARES INC
EEFT EURONET WORLDWIDE INC.
DKS DICK'S SPORTING GOODS INC.
CUTR CUTERA INC.
CLR CONTINENTAL RESOURCES INC.
CHGG CHEGG INC.
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC.
AAT AMERICAN ASSETS TRUST INC.
QRHC QUEST RESOURCE HOLDING
NAUT NAUTILUS MARINE SERVICES
KMI KINDER MORGAN INC CLASS P
CTHR CHARLES & COLVARD LTD.
SELB SELECTA BIOSCIENCES
CLF CLIFFS NATURAL RESOURCES INC.
APTX APTINYX
FPAY FLEXSHOPPER
EVER EVERQUOTE
SAFE SAFEHOLD INC.
KFS KINGSWAY FINANCIAL SERVICES
OTLK OUTLOOK THERAPEUTICS
TWTR TWITTER
PHR INC.
ALIM PHREESIA
HGBL ALIMERA SCIENCES
TIG HERITAGE GLOBAL
ACET TREAN INSURANCE GROUP
RILY INC.
ATNF ADICET BIO INC
ABCL B. RILEY FINANCIAL
ALTO 180 LIFE SCIENCES CORP
BTRS ABCELLERA BIOLOGICS
OEG ALTO INGREDIENTS INC
XM BTRS HOLDINGS INC (A)
TSHA ORBITAL ENERGY GROUP
YELL QUALTRICS INTERNATIONAL
PFX TAYSHA GENE THERAPIES
LFMD YELLOW CORPORATION
CRCT PHENIXFIN CORP
VERV LIFEMD
CANO INC.
VWE CRICUT
CNTA INC.
XOS VERVE THERAPEUTICS
FORA INC.
STGW CANO HEALTH
AIMD INC.
VINTAGE WINE ESTATES INC
CENTESSA PHARMACEUTICALS PLC
XOS INC
FORIAN INC
STAGWELL INC
AINOS
INC.
- Jonathan Moreland
RVNC REVANCE THERAPEUTICS INC.
PRLB PROTO LABS INC.
PRGO PERRIGO CO. PLC
KIRK KIRKLAND'S INC.
CHGG CHEGG INC.
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC.
CTHR CHARLES & COLVARD LTD.
SELB SELECTA BIOSCIENCES
APTX APTINYX
VRCA VERRICA PHARMACEUTICALS
PRVB PROVENTION BIO INC
SAFE SAFEHOLD INC.
KFS KINGSWAY FINANCIAL SERVICES
ORGO ORGANOGENESIS HOLDINGS (A)
OTLK OUTLOOK THERAPEUTICS
ALIM ALIMERA SCIENCES
HGBL HERITAGE GLOBAL
TIG TREAN INSURANCE GROUP
FCRD INC.
OEG FIRST EAGLE ALTERNATIVE CAPITAL BDC INC
YELL ORBITAL ENERGY GROUP
VERV YELLOW CORPORATION
LZ VERVE THERAPEUTICS
CANO INC.
HCDI LEGALZOOM.COM
EFTR INC.
CNTA CANO HEALTH
XOS INC.
HARBOR CUSTOM DEVELOPMENT INC
EFFECTOR THERAPEUTICS INC
CENTESSA PHARMACEUTICALS PLC
XOS INC
- Jonathan Moreland
NVRO NEVRO CORP
GE GENERAL ELECTRIC COMPANY
SIX SIX FLAGS ENTERTAINMENT CORPORATION
VPG VISHAY PRECISION GROUP
PCRX PACIRA BIOSCIENCES INC.
MGNX MACROGENICS INC.
MCHX MARCHEX INC. CL B
HOMB HOME BANCSHARES INC.
FMNB FARMERS NATIONAL BANC CORP.
EIG EMPLOYERS HOLDINGS INC.
COMM COMMSCOPE HOLDING CO. INC.
CLDT CHATHAM LODGING TRUST
BLL BALL CORPORATION
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC.
BCOV BRIGHTCOVE
AXSM AXSOME THERAPEUTICS
OFIX ORTHOFIX INTERNATIONAL N.V.
QRHC QUEST RESOURCE HOLDING
NAUT NAUTILUS MARINE SERVICES
WHG WESTWOOD HOLDINGS GROUP INC.
BWFG BANKWELL FINANCIAL GROUP
VICI VICI PROPERTIES INC
TALO TALOS ENERGY INC.
EVRG EVERGY
ESTA INC.
FPAY ESTABLISHMENT LABS HOLDINGS
EVER FLEXSHOPPER
PRTS EVERQUOTE
FSK U.S. AUTO PARTS NETWORK
SAFE INC.
KFS FS KKR CAPITAL CORP
ORGO SAFEHOLD INC.
XAIR KINGSWAY FINANCIAL SERVICES
CCAP ORGANOGENESIS HOLDINGS (A)
TIG BEYOND AIR
GOCO CRESCENT CAPITAL BDC
ATCX INC.
BDSX TREAN INSURANCE GROUP
ONCR INC.
HIPO GOHEALTH
ALTO INC.
BVH ATLAS TECHNICAL CONSULTANTS INC (A)
DIBS BIODESIX
MKTW ONCORUS
BLFY HIPPO VALLEY ESTATES LTD
AUGX ALTO INGREDIENTS INC
AKYA BLUEGREEN VACATIONS HOLDING CORPORATION (A)
VWE 1STDIBS.COM
XOS INC.
FORA MARKETWISE
ARC INC.
ZEST BLUE FOUNDRY BANCORP
NSPR AUGMEDIX
INC.
AKOYA BIOSCIENCES INC
VINTAGE WINE ESTATES INC
XOS INC
FORIAN INC
AMERICAN REPROGRAPHICS CO.
ECOARK HLDGS INC
INSPIREMD INC
- Jonathan Moreland
NVRO NEVRO CORP
SIX SIX FLAGS ENTERTAINMENT CORPORATION
VPG VISHAY PRECISION GROUP
TXMD THERAPEUTICSMD INC.
LTRX LANTRONIX INC.
HOMB HOME BANCSHARES INC.
EIG EMPLOYERS HOLDINGS INC.
COMM COMMSCOPE HOLDING CO. INC.
CLDT CHATHAM LODGING TRUST
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC.
AXSM AXSOME THERAPEUTICS
OFIX ORTHOFIX INTERNATIONAL N.V.
BWFG BANKWELL FINANCIAL GROUP
VCTR VICTORY CAPITAL HOLDINGS CLASS A
TALO TALOS ENERGY INC.
KRP KIMBELL ROYALTY PARTNERS LP
FPAY FLEXSHOPPER
EVER EVERQUOTE
PRTS U.S. AUTO PARTS NETWORK
KFS INC.
ORGO KINGSWAY FINANCIAL SERVICES
LMPX ORGANOGENESIS HOLDINGS (A)
BIGC LMP AUTOMOTIVE HOLDINGS
TIG INC.
ATCX BIGCOMMERCE HOLDINGS
BDSX INC.
ONCR TREAN INSURANCE GROUP
OEG INC.
BVH ATLAS TECHNICAL CONSULTANTS INC (A)
UP BIODESIX
AI ONCORUS
NIHK ORBITAL ENERGY GROUP
AKYA BLUEGREEN VACATIONS HOLDING CORPORATION (A)
EFTR WHEELS UP EXPERIENCE INC.
VWE C3.AI
ROVR INC.
NIGHTHAWK SYSTEMS
AKOYA BIOSCIENCES INC
EFFECTOR THERAPEUTICS INC
VINTAGE WINE ESTATES INC
ROVER METALS CORP
Biodelivery Sciences International Inc: 1 director
A director at Biodelivery Sciences International Inc bought 100,000 shares at 3.060USD and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over t...
- Jonathan Moreland
NGL NGL ENERGY PARTNERS LP
KW KENNEDY-WILSON HOLDINGS INC.
EHTH EHEALTH INC.
EEFT EURONET WORLDWIDE INC.
DBD DIEBOLD NIXDORF INCORPORATED
CLR CONTINENTAL RESOURCES INC.
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC.
BCOV BRIGHTCOVE
AAT AMERICAN ASSETS TRUST INC.
HFC HOLLYFRONTIER CORPORATION
LPX LOUISIANA-PACIFIC CORPORATION
MGI MONEYGRAM INTERNATIONAL INC.
EPD ENTERPRISE PRODUCTS PARTNERS L.P.
MLI MUELLER INDUSTRIES INC.
BHVN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
ODT ODONATE THERAPEUTICS INC
APLS APELLIS PHARMACEUTICALS
EYEN EYENOVIA INC
EVER EVERQUOTE
FSK FS KKR CAPITAL CORP
SAFE SAFEHOLD INC.
PTON PELOTON INTERACTIVE
BIGC INC.
IHRT BIGCOMMERCE HOLDINGS
RILY INC.
RIDE IHEARTMEDIA INC. CLASS A
SKLZ B. RILEY FINANCIAL
ABCL LORDSTOWN MOTORS CORP (A)
FSR SKILLZ INC (A)
VOR ABCELLERA BIOLOGICS
BVH FISKER INC (A)
UAN VOR BIOPHARMA
ORGN BLUEGREEN VACATIONS HOLDING CORPORATION (A)
MKTW CVR PARTNERS LP
WISH ORIGIN MATERIALS
AI INC.
AKYA MARKETWISE
CNTA INC.
AUD CONTEXTLOGIC INC.
BGS C3.AI
INC.
AKOYA BIOSCIENCES INC
CENTESSA PHARMACEUTICALS PLC
AUDACY INC
B&G FOODS
INC.
- Jonathan Moreland
AAT AMERICAN ASSETS TRUST INC.
OFIX ORTHOFIX INTERNATIONAL N.V.
FCAP FIRST CAPITAL INC.
RGCO
FPAY RGC RESOURCES
EVER FLEXSHOPPER
STRA EVERQUOTE
FSK STRATEGIC EDUCATION INC.
ORGO FS KKR CAPITAL CORP
TELA ORGANOGENESIS HOLDINGS (A)
BDSX TELA BIO
OEG BIODESIX
BVH ORBITAL ENERGY GROUP
ZY BLUEGREEN VACATIONS HOLDING CORPORATION (A)
MKTW ZYMERGEN INC.
AKYA MARKETWISE
HCDI INC.
FORA AKOYA BIOSCIENCES INC
AUD HARBOR CUSTOM DEVELOPMENT INC
BLBX FORIAN INC
AUDACY INC
BLACKBOXSTOCKS INC
- Jonathan Moreland
NSSC NAPCO SECURITY SYSTEMS
NBHC NATIONAL BANK HOLDINGS
HSKA HESKA CORPORATION
EHTH EHEALTH INC.
CDTX CIDARA THERAPEUTICS
BDSI BIODELIVERY SCIENCES INTERNATIONAL INC.
BCOV BRIGHTCOVE
HFC HOLLYFRONTIER CORPORATION
TWLO TWILIO INC. CLASS A
APTX APTINYX
SAFE SAFEHOLD INC.
VOXX AUDIOVOX CORPORATION
HGBL HERITAGE GLOBAL
ABCL ABCELLERA BIOLOGICS
YELL YELLOW CORPORATION
CRCT CRICUT
BGSF INC.
HSDT BG STAFFING INC.
ARC HELIUS MEDICAL TECHNOLOGIES INC
AMERICAN REPROGRAPHICS CO.
BioDelivery Sciences Reports Solid Third Quarter 2021 Results
BioDelivery Sciences Reports Solid Third Quarter 2021 Results Total Net Revenue of $41.1 Million, an Increase of 4% versus Prior Year Strong profitability with GAAP EPS of $0.07, EBITDA Margin of 27% and $7.0 million Operating Cash Flow Closed acquisition of ELYXYB, the first FDA-approved, ready-to-use oral solution for acute migraine with potential long-term peak sales opportunity of $350 - $400 million Conference Call and Webcast Scheduled for 8:30 AM EST Today RALEIGH, N.C., Nov. 03, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a growing special...
BioDelivery Sciences Appoints John Golubieski as Chief Financial Offic...
BioDelivery Sciences Appoints John Golubieski as Chief Financial Officer RALEIGH, N.C., Oct. 21, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions, today announced the appointment of John Golubieski as Chief Financial Officer, effective November 4, 2021. Mr. Golubieski brings to BDSI more than 30 years of financial and operational experience and will serve as a member of the company’s executive leadership team. “I'm pleased to welcome J...
BioDelivery Sciences to Report Third Quarter 2021 Financial Results on...
BioDelivery Sciences to Report Third Quarter 2021 Financial Results on November 3, 2021 RALEIGH, N.C., Oct. 20, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a growing specialty pharmaceutical company dedicated to patients living with chronic conditions, announced today that it will report its third quarter 2021 financial results before the open of the U.S. financial markets on Wednesday, November 3, 2021. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations. Con...
BioDelivery Sciences International to Host ELYXYB™ Investor Day
BioDelivery Sciences International to Host ELYXYB™ Investor Day The First and Only FDA-Approved, Ready-to-Use Oral Solution for the Acute Treatment of Migraine with or without Aura in Adults Virtual Event on October 14, 2021 RALEIGH, N.C., Sept. 30, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a growing specialty pharmaceutical company dedicated to patients living with chronic conditions, announced today it will host a virtual ELYXYB™ Investor Day on Thursday, October 14, 2021, at 10:30am ET. The webinar will feature insights from migraine key opini...
BioDelivery Sciences International Completes Acquisition of ELYXYB™ fo...
BioDelivery Sciences International Completes Acquisition of ELYXYB™ for Acute Migraine Treatment in the U.S. and Canada Expands Portfolio and Establishes Growth Platform in Neurology The First and Only FDA-Approved, Ready-to-Use Oral Solution for the Acute Treatment of Migraine with or without Aura in Adults Commercial Launch Planned for Q1 2022 Investor Day on October 14, 2021 RALEIGH, N.C., Sept. 09, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a growing specialty pharmaceutical company dedicated to patients living with c...
BioDelivery Sciences to Exhibit Three Scientific Posters Comparing BEL...
BioDelivery Sciences to Exhibit Three Scientific Posters Comparing BELBUCA® to Oxycodone at the PAINWeek 2021 Conference RALEIGH, N.C., Sept. 07, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a growing specialty pharmaceutical company dedicated to patients living with chronic conditions, will showcase three scientific posters regarding BELBUCA® (buprenorphine buccal film), CIII at the PAINWeek 2021 Conference taking place September 7 – 11, 2021 at The Cosmopolitan of Las Vegas. The posters include: Risk Stratification of Respirator...
BioDelivery Sciences to Participate in Upcoming Virtual Investor Confe...
BioDelivery Sciences to Participate in Upcoming Virtual Investor Conferences RALEIGH, N.C., Sept. 03, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that Jeffrey Bailey, Chief Executive Officer, and Terry Coelho, Executive Vice President and Chief Financial Officer, will present and participate in one-on-one investor meetings at the H.C. Wainwright 23rd Annual Global Investment Conference taking place on September 1...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.